Ferromene

Quick links to important sections

Ferromene

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferromene

Quick Facts

Property Description
Active ingredient Ferrous Lactate (Iron (II) Lactate)
Form Tablets, Capsules, Oral Solution
Pharmacological Class Iron Preparation, Hematinic
Common Use Systemic iron supplementation for deficiency
Origin Synthetic/Semisynthetic mineral salt

Ferromene is classified as an antianemic agent and systemic iron supplement, designed to address and prevent states of iron deficiency. The primary function of this medicine is to restore the body's iron reserves, which are crucial for maintaining proper physiological function. This approach to treatment is clinically recognized for correcting the underlying mineral deficit responsible for insufficient blood health.

Ferrous Lactate: Composition and Form

The active component in this medicine is Ferrous Lactate, a highly bioavailable ferrous salt that delivers the necessary iron ion (Fe^2+) for absorption. Iron preparations of this type are used as agents to treat iron deficiency anemia.

Ferrous Lactate is considered a synthetic mineral compound intended for oral administration, and it is often positioned for patients requiring consistent, mild-to-moderate supplementation. The compound, which is formed by the reaction of iron with lactic acid, is recognized as a reliable source of bioavailable ferrous iron. Ferromene is available in conventional oral dosage form(s), including solid preparations like tablets and capsules, as well as an oral solution.

General Purpose

Ultimately, the general purpose of taking Ferromene is to support the body's ability to synthesize hemoglobin, which ensures that oxygen is efficiently transported to all tissues and organs. This action supports continuous red blood cell formation and energy metabolism, targeting conditions resulting from inadequate iron supply.

What side effects are possible with Ferromene?

Possible Side Effects and Safety Information

Ferromene is associated with a risk of Serious Hypersensitivity Reactions, which can be life-threatening and include anaphylaxis, cardiorespiratory arrest, clinically significant hypotension, and syncope. Due to this risk, the medicine must be administered only when personnel and therapies for treating anaphylaxis are immediately available, and patients should be observed for signs of hypersensitivity for at least 30 minutes after administration.

Adverse Reactions

The adverse reactions reported are formally categorized by frequency in regulatory documents:

Frequency Examples of Adverse Reactions (System Organ Classes)
Very Common (ge 1/10) Headache, Nausea, Dizziness, Injection/infusion site reactions (e.g., discoloration, pain)
Common (ge 1/100 to < 1/10) Diarrhea, Constipation, Peripheral edema, Hypotension, Flushing, Hypertension, Hypophosphatemia

Serious adverse reactions also include significant hypotension that may require intervention. Other organ systems involved include Gastrointestinal, Vascular, Nervous System, and Skin/Subcutaneous Tissue.

Safety Restrictions and Monitoring

Ferromene is contraindicated (must not be used) in patients with a history of allergy to this drug or any other intravenous (IV) iron product. It is also important to monitor patients for signs of iron overload and to avoid use if pre-existing iron overload is present. The use of this medicine in elderly patients and during pregnancy requires particular caution, as these populations may experience more severe outcomes from hypersensitivity reactions.

Overdose and Emergency Response

Overdose and when to seek help

Feature Official Regulatory Statement
Documented Overdose Presentations Overdose symptoms are typically biphasic. The initial phase (0.5 to 6 hours) includes severe gastrointestinal symptoms like vomiting (with or without blood), diarrhea, and abdominal pain. Systemic signs documented include hypotension, tachycardia, and lethargy.
Dose-Related Factors Ingestion of elemental iron doses of 40 mg/ kg or greater warrants medical evaluation. Doses of 60 mg/ kg are cited in regulatory literature as potentially lethal in children. The absence of symptoms after six hours may suggest significant toxicity is unlikely.
Population-Specific Overdose Notes Accidental overdose of iron-containing products is officially documented as a leading cause of fatal poisoning in children under 6 years of age.
Emergency-Response Statements Seek immediate medical attention or call a poison control center immediately for any suspected or known overdose. Urgent help is required for severe manifestations, including collapse, seizures, or signs of shock, which may progress to metabolic acidosis and organ failure.

Official Overdose Management:

  • Overdose is classified as potentially severe or life-threatening due to the risk of shock, metabolic acidosis, and hepatic/renal failure.
  • The specific chelating agent Deferoxamine is officially described for managing severe systemic toxicity when specific iron levels are exceeded.
  • Supportive care, continuous monitoring of serum iron levels, and a minimum six-hour observation period are documented requirements.

Connection to the overall overdose profile

The regulatory documentation defines the ferrous lactate overdose profile based on the severity and rapid progression of elemental iron toxicity, classifying it as potentially life-threatening. The official profile mandates that the public seek immediate medical attention for any suspected overdose and documents the specific clinical management procedures, including the use of the antidote, Deferoxamine, and continuous patient monitoring.

Therapeutic Uses of Ferromene

What Ferromene Treats: Main Uses and Benefits

Ferromene is generally applied to provide symptomatic relief in conditions marked by systemic imbalance, specifically those driven by inadequate iron levels. The medication may assist with managing symptomatic discomfort and supporting functional stability.

Ferromene is relevant for use in conditions where symptoms are related to systemic imbalance, such as those associated with iron deficiency. Oral iron is utilized to help manage or prevent this type of anemia when dietary intake is insufficient. It is used for managing manifestations like fatigue, weakness, and difficulty with concentration.


Easing Symptoms and Supporting Stability

Ferromene helps address symptom clusters that may become intense or disruptive, contributing to easing the overall symptom load and supporting patients during difficult episodes by easing distress. The medication is relevant in conditions characterized by periods of heightened symptoms and is commonly used when short-term symptomatic assistance is needed.

Quick Fact: Focus on Physiological Strain

Ferromene may assist with maintaining a sense of stability when symptoms are more noticeable, supporting patients during episodes of heightened discomfort that interfere with routine activities. This supportive relief is applied in clinical settings that involve acute or unstable symptom patterns.

Regulatory References

  1. MedlinePlus overview on Iron Supplements

Eligibility and Restrictions for Use

Eligibility Scope

Ferromene is formally classified for use in individuals with documented iron deficiency anemia. The core eligibility rule is confirmation of an actual iron deficit; the medicine is generally for adults and adolescents whose condition requires systemic iron supplementation.

Contraindicated Populations

Use is strictly prohibited for patients with established Iron Overload Syndromes, including hemochromatosis and hemosiderosis, due to the severe risk of iron toxicity. The medicine is also contraindicated for patients receiving repeated blood transfusions and those with hemolytic anemia or any anemia not attributed to iron deficiency. Patients with a known hypersensitivity to any ferrous salt must not use this medicine.

Age and Condition Restrictions

Standard oral formulations carry a prominent WARNING against use in children under 6 years of age. Regulatory agencies mandate this due to the high risk of fatal poisoning from accidental overdose in this population. Use is restricted or not recommended in patients with severe gastrointestinal conditions, such as active Inflammatory Bowel Disease or acute stomach ulcers, as oral iron may exacerbate the condition. For pregnant and lactating individuals with a documented deficiency, use is generally considered acceptable.

What should I know about interactions with other medicines?

Ferromene, as an oral ferrous salt, has an official interaction profile defined primarily by chemical binding and absorption interference within the gastrointestinal tract. This profile establishes clear constraints on co-administration with other medicines and products.

Exposure-Modifying Interactions Requiring Separation

Co-administration with several medicinal products may result in a mutual reduction of absorption, leading to decreased systemic exposure for Ferromene and the interacting agent. This pharmacokinetic interaction occurs with substances such as Levothyroxine, Bisphosphonates (e.g., Alendronic acid), and specific antibiotic classes including tetracyclines and fluoroquinolones. To prevent this reduction in efficacy, regulatory guidelines require these agents be administered separated by an interval of at least two to several hours from Ferromene.

Interaction-Related Restrictions and Food

The systemic exposure of Ferromene is also reduced when co-administered with pH-altering agents like certain antacids, as well as with calcium in dairy products and tannins/polyphenols in tea and coffee. The label lists formal prohibitions: Ferromene is restricted with Dimercaprol due to the potential for increased nephrotoxic activities, and is formally prohibited with parenteral iron preparations to avoid the documented risk of severe iron overload syndromes.

Mechanism of Action

The mechanism of Ferromene (Ferrous Lactate) is an elemental replenishment action that provides the necessary iron substrate for critical physiological processes. The action proceeds through two primary domains: highly regulated intestinal transport and subsequent utilization in metabolic pathways.

Intestinal Absorption and Systemic Transport

This domain covers the critical initial steps where the ferrous ion ( Fe^2+) is made available and transported. The Fe^2+ is actively moved from the gut into the bloodstream primarily via specific protein channels like DMT1 and Ferroportin. This process ensures the iron is captured by the main plasma carrier, Transferrin, which facilitates systemic distribution to utilization sites.

Heme Synthesis and Cellular Bioenergetics

The systemic mechanism involves the delivery of iron to the bone marrow where it is integrated into the Heme Biosynthesis Pathway, supporting the creation of Hemoglobin and oxygen-carrying red blood cells. Simultaneously, the iron supports non-hemoglobin functions by enabling the synthesis of Myoglobin and the operation of iron-containing enzymes (e.g., cytochromes) involved in cellular energy metabolism across all tissues.

Dosage and Administration Information

Ferromene is approved solely for oral administration and is supplied in solid dosage forms, such as tablets and capsules, and as an oral solution. The prescribed amount is standardized based on the quantity of elemental iron delivered. For adult treatment, guidelines typically specify a dose equivalent to 65 mg elemental iron per day. Administration protocols may endorse a once-daily or alternate-day schedule to enhance absorption and patient tolerability.

To optimize absorption, the medicine should ideally be taken on an empty stomach—at least one hour before or two hours after a meal. If this causes gastrointestinal discomfort, the dose may be administered with or immediately after food, though this may lead to a reduced rate of absorption. Solid dosage forms must be swallowed whole with water; they are not to be sucked, chewed, or crushed. Liquid preparations require precise measurement using a calibrated measuring device.

To prevent diminished absorption, the dose should be separated from and not taken concurrently with substances like milk, tea, coffee, or antacids. The duration of the course is generally prolonged, requiring continued administration for a minimum of three to six months after blood parameters normalize to ensure the full replenishment of iron stores. If a regular dose is missed, standard practice involves skipping the forgotten dose and maintaining the regular schedule; a double dose must not be taken.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ferromene

Ferromene, which contains a type of oral ferrous salt, Ferrous Lactate, was studied for its use within a broader class of iron preparations. The research available contributes to the overall understanding of how these supplements were studied in various forms of iron deficiency.


Evidence for Use in Iron Deficiency Anemia (IDA)

The core research on oral iron preparations was studied for its use in Iron Deficiency Anemia (IDA). Researchers have conducted numerous short-term to intermediate-term studies, primarily Randomized Controlled Trials (RCTs) and Systematic Reviews, involving Adults and targeted populations such as Pregnant Women.

Studies explored time-dependent changes in hematologic biomarkers, including Hemoglobin (Hb) and Serum Ferritin. The findings from this body of evidence describe patterns observed during the study periods, and data show patterns related to changes in these hematologic markers. This evidence contributes to the broader evidence landscape supporting the study of oral ferrous salts for replenishing the deficient mineral.

However, certain aspects remain uncertain. The long-term durability of these effects on iron stores beyond the initial treatment phase is not fully established. Furthermore, existing studies provide limited insight into the real-world impact of patient adherence, which is often cited as a factor that may influence outcomes outside of a controlled trial setting.


Evidence for Use in Iron Deficiency Without Anemia (IDWA)

Research has explored the use of oral iron in individuals who have Iron Deficiency Without Anemia (IDWA). Studies were applied in research contexts involving individuals whose symptoms, such as fatigue and general weakness, were studied as outcomes. Findings related to symptom change were mixed across different studies, and certainty remains low regarding the extent of short-term changes specifically for these isolated symptoms. Evidence related to functional outcomes remains limited. The findings were not uniform across all studies.


The Quality and Limitations of the Evidence

The evidence level regarding core blood health markers is High. This research, however, is subject to several documented limitations. Sample sizes were modest in some specialized studies, and the results apply only to the populations studied. Data for certain functional groups are limited, and subgroup findings are uncertain regarding the full extent of non-hematologic outcomes.

Key Studies & References

  1. Effect of Iron Supplementation on Symptoms in Non-Anemic Iron-Deficient Adults: A Systematic Review and Meta-analysis
  2. Iron Products (Oral Route): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Ferromene (FAQ)


Q: How long does it usually take before I might notice the effects of Ferromene?

Official guidance indicates that replenishing the body's iron stores, as measured by blood parameters, typically requires consistent use over several months. However, effects on symptoms like fatigue are often described in research as being observed within the first few weeks of starting treatment. The duration of the course is typically determined by a healthcare provider based on the patient's individual parameters.


Q: Is it normal to feel tired when starting Ferromene treatment?

Official safety documents list common adverse reactions, but they do not typically list general fatigue or tiredness as a formal side effect of the medicine itself. For any concerns about symptoms, including tiredness, individuals are generally advised to discuss them with a healthcare provider.


Q: Are there any known issues with taking Ferromene long-term?

Official documentation notes that treatment is generally prolonged, often lasting for many months to ensure iron stores are fully built up. A main safety risk with excessive long-term therapy is the development of iron overload (hemosiderosis). Ongoing patient monitoring is generally conducted to help mitigate this risk.


Q: Does Ferromene interact with common vitamins like Vitamin C or B12?

Regulatory documents describe that the absorption of Ferromene may be enhanced by substances like Vitamin C ( Ascorbic Acid). Conversely, the absorption of Ferromene may be reduced when taken at the same time as certain other mineral supplements. It is generally advisable to disclose all supplements and vitamins to a healthcare provider.


Q: What should I do if I experience a side effect listed as 'less common'?

General patient information from official sources advises that individuals are advised to contact a healthcare provider if they experience any side effect that is bothersome, persistent, or causes them concern. If signs of a serious reaction occur, such as a severe allergic reaction, immediate medical help is often advised.


Q: Can Ferromene be used for iron deficiency anemia in children?

Official labels include a prominent warning against using this oral iron preparation in children under 6 years of age due to the high risk of fatal poisoning from accidental overdose. Use in children 6 years and older is typically determined by a healthcare professional and only with a confirmed diagnosis of iron deficiency.


Q: What happens if I forget to take a dose of Ferromene?

Regulatory instructions clearly advise that if a regular dose of Ferromene is missed, the forgotten dose should be skipped entirely and the regular schedule should be maintained. Regulatory instructions advise against taking a double dose to make up for a forgotten dose.


Q: Is Ferromene known to interact with blood pressure medications?

The official interaction profile includes substances that may cause a mutual reduction in absorption when taken with Ferromene. Some blood pressure medications, such as ACE inhibitors, have been documented in regulatory sources to interact with ferrous salts, potentially requiring a time interval between administrations.


Q: Does Ferromene have any known effects on kidney function?

Official product information prohibits the co-administration of Ferromene with the drug Dimercaprol due to the potential for increased nephrotoxic (kidney-damaging) activities. This is the primary documented link to kidney function concerns in the regulatory text.


Q: What is the rationale behind the recommended dosing frequency for Ferromene?

Modern administration protocols, as supported by national health services, often endorse a once-daily or alternate-day schedule. This frequency is specifically recommended to help enhance intestinal absorption of the iron and potentially improve patient tolerability of the medicine.


Q: What kind of patient monitoring is typically recommended during Ferromene therapy?

During Ferromene therapy, official guidelines recommend monitoring patients for signs of iron overload. This involves the periodic testing of hematologic (blood-related) and iron parameters, such as hemoglobin, serum ferritin, and transferrin saturation ( TSAT).


Q: Can Ferromene be used by people who are vegetarian or vegan?

The active ingredient, Ferrous Lactate, is a synthetic mineral compound that is not sourced from animals, making it generally considered suitable for vegetarian and vegan diets. However, the full composition may be reviewed for any non-active ingredients, or 'excipients', which can vary by formulation.


Q: What kind of studies or research support the use of Ferromene?

The use of Ferromene is supported by a body of evidence, including Randomized Controlled Trials ( RCTs) and Systematic Reviews. These studies examined time-dependent changes in blood markers like Hemoglobin and Serum Ferritin in adults and specific populations like pregnant women.


Q: Does Ferromene interact with commonly used painkillers like ibuprofen?

Official interaction sections do not typically list non-steroidal anti-inflammatory drugs ( NSAIDs) such as ibuprofen as directly interfering with Ferromene absorption. Since both agents can affect the gastrointestinal tract, caution is advised, particularly for patients with pre-existing GI conditions.


Q: Does taking Ferromene affect the results of certain lab tests?

Official monitoring recommendations note that blood iron parameters, such as Transferrin Saturation ( TSAT), may increase rapidly following iron administration. To avoid potentially inaccurate results, serum iron measurements should not be performed immediately after a dose is taken.


Q: Does Ferromene contain gluten, lactose, or common allergens?

While the active ingredient, Ferrous Lactate, is not inherently an allergen, official documents provide a full list of inactive ingredients ( excipients). These ingredients can vary by product formulation, so individuals with specific allergies may wish to review the full excipient list for their version of the medicine.


Q: Are there any warnings about driving or operating machinery while taking Ferromene?

Official product information sometimes advises patients to be cautious about driving or operating machinery if they experience certain adverse reactions. This includes very common side effects such as dizziness or headache.


Q: Are there special considerations for people with inflammatory bowel conditions using Ferromene?

Official documents advise that the use of oral iron is restricted or not recommended in patients who have severe gastrointestinal conditions, such as active Inflammatory Bowel Disease ( IBD) or acute stomach ulcers. This is because oral iron may potentially worsen these conditions.


Q: How do studies describe the general tolerability of Ferromene?

The general tolerability of Ferromene is characterized by the Adverse Reaction profile listed in official documents. The most common side effects involve the gastrointestinal tract ( nausea, diarrhea, constipation) and the central nervous system ( headache, dizziness).


Q: Does Ferromene interact with alcohol?

The official interaction profile typically does not list a specific formal drug-alcohol interaction. However, some patient guidance suggests that alcohol may interfere with the body's iron absorption and could potentially worsen common gastrointestinal side effects.


Q: How quickly is the iron from Ferromene typically absorbed into the body?

The Mechanism of Action describes that the ferrous ion ( Fe^2+) is actively transported from the gut into the bloodstream via specific protein channels. The exact time frame for absorption in the general population is typically not specified in the patient materials.


Q: Does Ferromene cause changes in stool color, and is this concerning?

Official patient information for oral iron preparations commonly describes that the medicine may cause your stool (poo) to appear darker than usual, which can sometimes be black. This change in color is a very common and expected finding and is generally not considered a cause for concern.

How should Ferromene be stored and disposed of?

How to Store and Dispose of Ferromene (Ferrous Lactate)

Official regulatory guidelines define strict conditions for the storage and disposal of Ferromene, an oral iron preparation, to maintain its stability and ensure public safety.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Must be protected from moisture and excessive heat.
Container Keep in the original container and ensure it is tightly closed.
Child Safety Mandatory to store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Ferromene must be disposed of according to local regulations for pharmaceutical waste. Do not flush the medicine down a toilet or pour it into a drain unless specific instruction to do so is provided by a governmental authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferromene found in:

A-Z Index: